Design, synthesis and biological activity of dimeric pyrazolo[3,4-d]pyrimidin-4-one derivatives as selective SHP2 orthosteric inhibitors
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Yashuai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Drug Design, Pyrazoles, Pyrimidines. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Beijing Natural Science Foundation.
Abstract (Originalsprache)
SHP2 is a key oncoprotein and a promising target in various types of blood cancers and solid tumors. Here, we report the discovery of a novel series of dimeric pyrazolo[3,4-d]pyrimidin-4-one derivatives as potent SHP2 inhibitors. Among them, compound A4 exhibited potent inhibitory activity against both SHP2WT and SHP2E76K, and it demonstrated dose-dependent activity against the SHP2 protein tyrosine phosphatase (PTP) domain. At the cellular level, A4 significantly suppressed the proliferation of MV-4-11, KYSE520, HCT116, MDA-MB-231 and HepG2 cell lines. Further mechanistic studies revealed that A4 downregulated SHP2-mediated phosphorylation of AKT and ERK, and induced apoptosis in MV-4-11 cells. Molecular docking revealed a comprehensive network of interactions between A4 and the SHP2-PTP domain, providing a structural basis for its potent inhibitory activity. Collectively, this work identifies compound A4 as a promising selective SHP2 orthosteric inhibitor with a distinct chemical scaffold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210046, China.
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210046, China. Electronic address: sunyangnju@163.com.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.. Electronic address: xbmeng@bjmu.edu.cn.
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Wang, Y., Shao, X., Wang, M., Li, Z., Sun, Y., & Meng, X. (2026). Design, synthesis and biological activity of dimeric pyrazolo[3,4-d]pyrimidin-4-one derivatives as selective SHP2 orthosteric inhibitors. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109573
Vancouver
Wang Y, Shao X, Wang M, Li Z, Sun Y, Meng X. Design, synthesis and biological activity of dimeric pyrazolo[3,4-d]pyrimidin-4-one derivatives as selective SHP2 orthosteric inhibitors. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109573
BibTeX
@article{Wang2026,
author = {Wang, Yashuai and Shao, Xiaoyu and Wang, Meijing and Li, Zhongjun and Sun, Yang and Meng, Xiangbao},
title = {Design, synthesis and biological activity of dimeric pyrazolo[3,4-d]pyrimidin-4-one derivatives as selective SHP2 orthosteric inhibitors},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109573}
}
EUVIMED